Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Ursolic acid benzaldehyde chalcone leads to inhibition of cell proliferation and arrests cycle in G1/G0 phase in ovarian cancer
Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon
Ursodeoxycholic acid attenuates experimental autoimmune arthritis by targeting Th17 and inducing pAMPK and transcriptional corepressor SMILE
Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016)
Ursolic acid suppresses leptin-induced cell proliferation in rat vascular smooth muscle cells
Ursolic acid improves podocyte injury caused by high glucose
Ursolic acid attenuates cigarette smoke-induced emphysema in rats by regulating PERK and Nrf2 pathways
Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats
Ursodeoxycholic acid for cystic fibrosis-related liver disease (Review)
Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis
Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis
Ursolic acid suppresses TGF-beta 1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling
Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K/AKT and NF-kappa B signaling pathways in vitro
Ursolic Acid Suppresses Hepatitis B Virus X Protein-mediated Autophagy and Chemotherapeutic Drug Resistance
Ursolic acid, a natural pentacylcic triterpene from Ochrosia elliptica and its role in the management of certain neglected tropical diseases
Ursolic acid protects MC3T3-E1 cells against dexamethasone-mediated apoptosis, ROS generation and inflammation through activation of IGF-1
Ursodeoxycholic acid treatment is associated with improvement of liver stiffness in cystic fibrosis patients
Ursodeoxycholic Acid in Primary Sclerosing Cholangitis: If Withdrawal Is Bad, Then Administration Is Good (Right?)
Ursodeoxycholic acid for cystic fibrosis-related liver disease
Ursodeoxycholic acid in primary sclerosing cholangitis
Ursodeoxycholic acid therapy in cystic fibrosis liver disease - a retrospective long-term follow-up case-control study
Ursodeoxycholic acid stimulates the formation of the bile canalicular network
Ursodeoxycholic acid for cystic fibrosis-related liver disease
Ursodeoxycholic acid in cystic fibrosis-associated liver disease Response
Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice
Ursodeoxycholic acid for primary biliary cirrhosis
Ursolic acid derivatives from Bangladeshi medicinal plant, Saurauja roxburghii: Isolation and cytotoxic activity against A431 and C6 glioma cell lines
Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection
Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment